The dysregulation of SHP2 has been implicated in the pathogenesis of many human diseases, such as Noonan syndrome (NS), LEOPARD syndrome (LS), and multiple types of cancers, including leukemia, lung and breast cancer, liver cancer and neuroblastoma [17,19,20,21]. Here, PTPN11 is linked to cancer.